למודקס 100 מג טבליות מסיסותלעיסות ישראל - עברית - Ministry of Health

למודקס 100 מג טבליות מסיסותלעיסות

dexcel ltd, israel - lamotrigine - טבליות הניתנות לפיזור\לעיסה - lamotrigine 100 mg - lamotrigine - lamotrigine - epilepsy : monotherapy in adults and children over 12 years of age : simple partial seizures. complex partial seizures. generalised tonic clonic secondarily seizures. primary generalised tonic clonic seizures. add-on therapy in adults and children over 2 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seizures. adults (18 years of age and over) lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

למודקס 200 מג טבליות מסיסותלעיסות ישראל - עברית - Ministry of Health

למודקס 200 מג טבליות מסיסותלעיסות

dexcel ltd, israel - lamotrigine - טבליות הניתנות לפיזור\לעיסה - lamotrigine 200 mg - lamotrigine - lamotrigine - epilepsy : monotherapy in adults and children over 12 years of age : simple partial seizures. complex partial seizures. generalised tonic clonic secondarily seizures. primary generalised tonic clonic seizures. add-on therapy in adults and children over 2 years of age: simple partial seizures. complex partial seizures. secondarily generalised tonic clonic seizures. adults (18 years of age and over) lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

לבטיראצטם טבע ® 250 מ"ג ישראל - עברית - Ministry of Health

לבטיראצטם טבע ® 250 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 250 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם טבע ® 500 מ"ג ישראל - עברית - Ministry of Health

לבטיראצטם טבע ® 500 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 500 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם טבע ® 1000 מ"ג ישראל - עברית - Ministry of Health

לבטיראצטם טבע ® 1000 מ"ג

teva pharmaceutical indust.ltd - levetiracetam 1000 mg - tablets - levetiracetam - - levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.- levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

פייקומפה 2 מג טבליות מצופות ישראל - עברית - Ministry of Health

פייקומפה 2 מג טבליות מצופות

eisai israel ltd., israel - perampanel as anhydrous - טבליות מצופות פילם - perampanel as anhydrous 2 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.

פייקומפה 4 מג טבליות מצופות ישראל - עברית - Ministry of Health

פייקומפה 4 מג טבליות מצופות

eisai israel ltd., israel - perampanel as anhydrous - טבליות מצופות פילם - perampanel as anhydrous 4 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.

פייקומפה 6 מג טבליות מצופות ישראל - עברית - Ministry of Health

פייקומפה 6 מג טבליות מצופות

eisai israel ltd., israel - perampanel as anhydrous - טבליות מצופות פילם - perampanel as anhydrous 6 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.

פייקומפה 8 מג טבליות מצופות ישראל - עברית - Ministry of Health

פייקומפה 8 מג טבליות מצופות

eisai israel ltd., israel - perampanel as anhydrous - טבליות מצופות פילם - perampanel as anhydrous 8 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.

פייקומפה 10 מג טבליות מצופות ישראל - עברית - Ministry of Health

פייקומפה 10 מג טבליות מצופות

eisai israel ltd., israel - perampanel as anhydrous - טבליות מצופות פילם - perampanel as anhydrous 10 mg - perampanel - perampanel - fycompa is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.